MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

MDT

83.06

+0.24%↑

VEEV

213.48

-0.09%↓

A

103.34

+2.82%↑

HQY

80.25

+4.9%↑

PDCO

30.85

-0.29%↓

Search

Veracyte Inc

Geschlossen

BrancheGesundheitswesen

29.48 2.75

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

27.05

Max

30.28

Schlüsselkennzahlen

By Trading Economics

Einkommen

-10M

5.1M

Verkäufe

2.8M

119M

KGV

Branchendurchschnitt

95.645

63.778

EPS

0.36

Gewinnspanne

4.31

Angestellte

824

EBITDA

-13M

9.7M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+54.44% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-1.2B

2.3B

Vorheriger Eröffnungskurs

26.73

Vorheriger Schlusskurs

29.48

Nachrichtenstimmung

By Acuity

12%

88%

11 / 386 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

Veracyte Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

7. Apr. 2025, 23:56 UTC

Top News

Australian Consumer Confidence Firms Despite Market Falls

7. Apr. 2025, 23:45 UTC

Heiße Aktien

Stocks to Watch: CVS Health, UnitedHealth Group, Spire Global, Pacira BioSciences

7. Apr. 2025, 21:36 UTC

Wichtige Markttreiber

Medicare Insurer Shares Rise on Plans for Higher Payment Rates

7. Apr. 2025, 21:11 UTC

Wichtige Markttreiber

Broadcom Authorizes $10 Billion Share Repurchase Program

7. Apr. 2025, 20:25 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Levi Strauss Posts 1Q Revenue Growth, Backs Guidance Amid 'Uncertain Environment'

7. Apr. 2025, 23:48 UTC

Market Talk

Nikkei May Rise After Recent Selloffs -- Market Talk

7. Apr. 2025, 23:47 UTC

Market Talk

Gold Edges Lower Amid More Cautious Near-Term Outlook -- Market Talk

7. Apr. 2025, 21:43 UTC

Market Talk

Oil Producers Choosing Returns Over Growth In Tariffs Fallout -- Market Talk

7. Apr. 2025, 21:37 UTC

Market Talk

Canada Faces Financial Crisis-Like Symptoms That Rate Cuts Won't Cure -- Market Talk

7. Apr. 2025, 21:32 UTC

Akquisitionen, Fusionen, Übernahmen

Infineon: All-Cash Transaction to Be Financed From Existing Liquidity and Additional Debt >IFX.FF

7. Apr. 2025, 21:32 UTC

Akquisitionen, Fusionen, Übernahmen

Infineon: Transaction Combines Infineon's Portfolio for Automotive Microcontrollers With Automotive Ethernet Business of Marvell, Accelerating Infineon's System Capabilities for Software-Defined Vehicles >IFX.FF

7. Apr. 2025, 21:32 UTC

Akquisitionen, Fusionen, Übernahmen

Infineon: Business Expected to Generate Rev of $225M-$250M in Calendar Yr 2025 With Gross Margin of Around 60% >IFX.FF

7. Apr. 2025, 21:32 UTC

Akquisitionen, Fusionen, Übernahmen

Infineon: Enters Agreement for Acquisition of Marvell Technology's Automotive Ethernet Business for US$2.5 B >IFX.FF

7. Apr. 2025, 21:31 UTC

Top News

Apple Plans to Source More iPhones From India as Potential Tariff Fix -- Update

7. Apr. 2025, 21:29 UTC

Top News

PNC Names Former BlackRock Star Mark Wiedman as President -- WSJ

7. Apr. 2025, 21:28 UTC

Akquisitionen, Fusionen, Übernahmen

Infineon Further Strengthens Its Number One Position In Automotive Microcontrollers And Boosts Systems Capabilities For Software-defined Vehicles With Acquisition Of Marvell's Automotive Ethernet Business >IFNNY MRVL

7. Apr. 2025, 21:21 UTC

Top News

Defense Stocks Can't Escape the Trade War. Expect to Hear This Term. -- Barrons.com

7. Apr. 2025, 21:18 UTC

Top News
Ergebnisse

Levi Strauss Trying to Mitigate Tariff Impact on Consumer; Company Grows Revenue -- Update

7. Apr. 2025, 21:17 UTC

Ergebnisse

Levi Sees U.S. Consumer 'Generally Resilient,' CFO Says

7. Apr. 2025, 21:17 UTC

Ergebnisse

Levi Looking at Cost-Related Opportunities, Pricing Changes as Part of Response, CFO Says

7. Apr. 2025, 21:16 UTC

Ergebnisse

Levi Strauss Sets Up Task Force to Understand Implications of Trump's Tariffs, CFO Singh Says

7. Apr. 2025, 21:16 UTC

Top News

What to Know About Trump's Latest Tariffs -- 3rd Update

7. Apr. 2025, 21:15 UTC

Akquisitionen, Fusionen, Übernahmen

Marvell to Sell In-Vehicle Network Portfolio for $2.5B

7. Apr. 2025, 21:14 UTC

Top News

PNC Taps Ex-BlackRock Star Mark Wiedman as President -- WSJ

7. Apr. 2025, 21:06 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

Trump Orders New Review of Nippon-U.S. Steel Merger -- 3rd Update

7. Apr. 2025, 20:59 UTC

Top News

U.S. Stock Meltdown Gives Way to Global Rout -- WSJ

7. Apr. 2025, 20:56 UTC

Wichtige Markttreiber

Broadcom Authorizes $10B Share Repurchase Program

7. Apr. 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

7. Apr. 2025, 20:33 UTC

Top News

Markets Swing Wildly After Trump Holds His Ground on Tariff Plan -- WSJ

7. Apr. 2025, 20:29 UTC

Top News

Tesla Stock Tanks Again. Price Target Slashed 43% Amid Musk's 'Brand Crisis Tornado.' -- Barrons.com

Peer-Vergleich

Kursveränderung

Veracyte Inc Prognose

Kursziel

By TipRanks

54.44% Vorteil

12-Monats-Prognose

Durchschnitt 44.71 USD  54.44%

Hoch 51 USD

Tief 29 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Veracyte Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

8 ratings

7

Buy

0

Halten

1

Sell

Technischer Score

By Trading Central

28.52 / 30.12Unterstützung & Widerstand

Kurzfristig

Bearish Evidence

Mittelfristig

Strong Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

11 / 386 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

$

Über Veracyte Inc

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.